These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 7086982)

  • 1. Should patients with single renal stone occurrence undergo diagnostic evaluation?
    Pak CY
    J Urol; 1982 May; 127(5):855-8. PubMed ID: 7086982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria.
    Pak CY; Britton F; Peterson R; Ward D; Northcutt C; Breslau NA; McGuire J; Sakhaee K; Bush S; Nicar M; Norman DA; Peters P
    Am J Med; 1980 Jul; 69(1):19-30. PubMed ID: 6247914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five years of experience with selective therapy in recurrent calcium nephrolithiasis.
    Elomaa I; Ala-Opas M; Porkka L
    J Urol; 1984 Oct; 132(4):656-61. PubMed ID: 6088813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High urinary excretion of uric acid combined with high excretion of calcium links kidney stone disease to familial hypertension.
    Tisler A; Pierratos A; Honey JD; Bull SB; Rosivall L; Logan AG
    Nephrol Dial Transplant; 2002 Feb; 17(2):253-9. PubMed ID: 11812875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma osteocalcin levels in stone disease. A potential aid in the differential diagnosis of calcium nephrolithiasis.
    Urivetzky M; Anna PS; Smith AD
    J Urol; 1988 Jan; 139(1):12-4. PubMed ID: 2826825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic changes in 2612 patients with nephrolithiasis].
    del Valle E; Spivacow R; Zanchetta JR
    Medicina (B Aires); 1999; 59(5 Pt 1):417-22. PubMed ID: 10684159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid-related nephrolithiasis.
    Low RK; Stoller ML
    Urol Clin North Am; 1997 Feb; 24(1):135-48. PubMed ID: 9048857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of calcium nephrolithiasis with potassium citrate.
    Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
    J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis.
    Sakhaee K; Poindexter JR; Pak CY
    J Urol; 1989 Apr; 141(4):819-21. PubMed ID: 2926871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic evaluation of nephrolithiasis in patients with medullary sponge kidney.
    O'Neill M; Breslau NA; Pak CY
    JAMA; 1981 Mar; 245(12):1233-6. PubMed ID: 7206112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of blood tests in screening for metabolic disorders in kidney stone disease.
    Eyre KS; Lewis F; Cui H; Grout E; Mihai R; Turney BW; Howles SA
    BJU Int; 2021 May; 127(5):538-543. PubMed ID: 32967050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal calcium excretion and urolithiasis].
    Aruga S; Honma Y
    Clin Calcium; 2011 Oct; 21(10):1465-72. PubMed ID: 21960231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic abnormalities associated with renal calculi in patients with horseshoe kidneys.
    Raj GV; Auge BK; Assimos D; Preminger GM
    J Endourol; 2004 Mar; 18(2):157-61. PubMed ID: 15072623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic evaluation of recurrent idiopathic calcium stone disease in Portugal].
    Serra A; Domingos F; Salgueiro C; Prata MM
    Acta Med Port; 2004; 17(1):27-34. PubMed ID: 15636725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is selective therapy of recurrent nephrolithiasis possible?
    Pak CY; Peters P; Hurt G; Kadesky M; Fine M; Reisman D; Splann F; Caramela C; Freeman A; Britton F; Sakhaee K; Breslau NA
    Am J Med; 1981 Oct; 71(4):615-22. PubMed ID: 7282750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.